Building the bridge between institutional capital and regulated cannabis markets through compliance, transparency, and expertise.
Smoke Profits was founded in 2018 by a team of pharmaceutical executives, agricultural specialists, and investment professionals who recognized a critical gap in the market: the need for institutional-grade investment access to the rapidly expanding cannabis sector.
As regulatory frameworks evolved and clinical research demonstrated the therapeutic potential of cannabis-derived treatments, we saw an opportunity to create a compliant, transparent platform that would allow accredited investors to participate in this emerging market with the same rigor and professionalism expected in traditional pharmaceutical and agricultural investments.
Today, SMPR manages investments across three continents, partnering with licensed cultivators, GMP-certified processors, and regulated distributors to build a diversified portfolio focused on medical applications rather than recreational markets.
To provide institutional investors with compliant, transparent, and professionally managed access to the regulated cannabis market, while supporting the development of pharmaceutical-grade cannabis therapies that improve patient outcomes worldwide.
To become the premier institutional gateway to the global cannabis industry, recognized for our unwavering commitment to compliance, our rigorous investment standards, and our contribution to legitimizing cannabis as a mainstream therapeutic option.
These principles guide every decision we make and every partnership we form.
We never compromise on compliance. Every investment, every partnership, and every operation adheres to the strictest regulatory standards in every jurisdiction where we operate.
Our investors deserve complete visibility into their investments. We provide detailed reporting, regular updates, and open communication channels at every stage.
We prioritize evidence-based decision making, partnering with organizations that invest in research, clinical trials, and product development backed by science.
At the heart of our mission are the patients who benefit from cannabis therapies. We support partners who prioritize patient safety and therapeutic efficacy.
We employ sophisticated risk management strategies to protect investor capital, including diversification, insurance, and comprehensive due diligence.
We promote environmentally responsible cultivation practices and support partners who prioritize sustainable agriculture and carbon footprint reduction.
Decades of combined experience in pharmaceuticals, finance, agriculture, and regulatory compliance.
Chief Executive Officer
Former VP at Pfizer, 20+ years in pharmaceutical developmentChief Investment Officer
Former Managing Director at BlackRock, 15+ years in alternative investmentsChief Scientific Officer
PhD in Pharmacology, former FDA reviewer, cannabis research specialistChief Compliance Officer
Former SEC attorney, regulatory compliance expert in cannabis marketsChief Operations Officer
Former agricultural operations lead at Cargill, supply chain expertVP of Global Partnerships
International business development, EU and LATAM market specialistJoin the growing community of institutional investors who trust SMPR for compliant cannabis investment access.